| Literature DB >> 25796198 |
Wei-Erh Cheng1, Miao Ying Chang2, Jyun-Yan Wei3, Yen-Jen Chen4, Ming-Chei Maa5, Tzeng-Horng Leu6.
Abstract
Berberine is an isoquinoline with anti-inflammatory activity. We previously demonstrated that there was a loop of signal amplification between nuclear factor kappa B and Src for macrophage mobility triggered by the engagement of Toll-like receptors (TLRs). The simultaneous suppression of lipopolysaccharide (LPS)-mediated upregulation of inducible nitric oxide synthase, cyclooxygenase 2, and cell mobility in berberine-treated macrophages suggested Src might be a target of berberine. Indeed, th reduced migration, greatly suppressed Src induction in both protein and RNA transcript by berberine were observed in macrophages exposed to LPS, peptidoglycan, polyinosinic-polycytidylic acid, and CpG-oligodeoxynucleotides. In addition to Src induction, berberine also inhibited LPS-mediated Src activation in Src overexpressing macrophages and S-nitroso-N-acetylpenicillamine (a nitric oxide donor) could partly restore it. Moreover, berberine suppressed Src activity in fibronectin-stimulated macrophages and in v-Src transformed cells. These results implied that by effectively reducing Src expression and activity, berberine inhibited TLR-mediated cell motility in macrophages.Entities:
Keywords: Berberine; Berberine (PubChem CID: 2353); LPS (PubChem CID: 53481793); Macrophage migration; SNAP (PubChem CID: 5231); Src; Thioglycollate (PubChem CID: 5086465); Toll-like receptor
Mesh:
Substances:
Year: 2015 PMID: 25796198 DOI: 10.1016/j.ejphar.2015.03.013
Source DB: PubMed Journal: Eur J Pharmacol ISSN: 0014-2999 Impact factor: 4.432